scispace - formally typeset
M

Michael Moran

Researcher at Pfizer

Publications -  69
Citations -  11810

Michael Moran is an academic researcher from Pfizer. The author has contributed to research in topics: Medicine & SH2 domain. The author has an hindex of 28, co-authored 54 publications receiving 11332 citations. Previous affiliations of Michael Moran include McMaster University & Queen's University Belfast.

Papers
More filters
Journal ArticleDOI

SH2 and SH3 Domains: Elements that Control Interactions of Cytoplasmic Signaling Proteins

TL;DR: Observations suggest that SH2 and SH3 domains participate in the control of intracellular responses to growth factor stimulation.
Journal ArticleDOI

Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases

TL;DR: It is shown that GAP, and two co-precipitating proteins of relative molecular masses 62,000 and 190,000 (p62 and p190) are phosphorylated on tyrosine in cells that have been transformed by cytoplasmic and receptor-like tyrosin kinases, which supports the idea that SH2 sequences direct the interactions of cytopLasmic proteins involved in signal transduction.
Journal ArticleDOI

Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors

TL;DR: SH2 domains provide a common mechanism by which enzymatically diverse regulatory proteins can physically associate with the same activated receptors and thereby couple growth factor stimulation to intracellular signal transduction pathways.